Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The aim of the open multi-center study is to determine an efficient and safe dose and dosing
schedule of NKT-01 in induction of response in treatment of lupus nephritis.